While CXCL14-mediated tumor suppression and altered expression correlates with better patient survival in cancer such as head and neck, colorectal, and liver, CXCL14-mediated tumor promotion mostly occurs in tumors of the breast and pancreas. This evidence concerns the gene CXCL14 and breast neoplasm.